Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | +9.06% | +3.56% | -14.81% |
03-21 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M | MT |
03-21 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 4.64M 6.34M | Sales 2025 * | 2.75M 3.76M | Capitalization | 99.77M 136M |
---|---|---|---|---|---|
Net income 2024 * | -49M -66.98M | Net income 2025 * | -63M -86.11M | EV / Sales 2024 * | 21.5 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 36.3 x |
P/E ratio 2024 * |
-2.07
x | P/E ratio 2025 * |
-2.12
x | Employees | 66 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.65% |
1 day | +9.06% | ||
1 week | +3.56% | ||
Current month | -33.97% | ||
1 month | -32.68% | ||
3 months | -32.52% | ||
6 months | +33.98% | ||
Current year | -14.81% |
Managers | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 23-07-10 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-25 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-02-11 | |
Joseph Patti
BRD | Director/Board Member | 60 | 19-05-08 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 21-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.76 | +9.06% | 9,511 |
24-04-25 | 2.531 | +1.23% | 4,683 |
24-04-24 | 2.5 | -1.19% | 4,871 |
24-04-23 | 2.53 | +0.80% | 16,769 |
24-04-22 | 2.51 | -5.82% | 5,098 |
Delayed Quote Nyse, April 26, 2024 at 04:10 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.81% | 99.77M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ARMP Stock